Upcoming Visits

Upcoming FDA Visits:

Dates Topic FDA Visitors

September 20-22, 2017

 

Personalized Medicine and Molecular Genetics

 

David Litwack, PhD | Policy Advisor, Office of In Vitro Diagnostics and Radiological Health, CDRH

 

September 28, 2017

Global Substance Registration System

Larry Callahan, PhD | Lead Scientist- Substance Registration System, Office of Health Informatics, OCS
Leslie Kenna, PhD | Pharmacologist, Division of Scientific Support, Office of New Animal Drug Evaluation, CVM

 

October 2-3, 2017

CRISPR/Cas9 Genome Editing

Ying Huang, PhD | Pharmacologist, Division of Clinical Evaluation & Pharmacology/Toxicology/OTAT, CBER
Jakob Reiser, PhD | Principal Investigator, Division of Cellular & Gene Therapies/OTAT, CBER

 

November 2017

Cellular Immunotherapies

Kristin Baird, MD | Medical Officer, Division of Clinical Evaluation & Pharmacology/Toxicology/OTAT, CBER
Graeme Price, PhD | Research Microbiologist, Division of Cellular & Gene Therapies/OTAT, CBER

 

Public lectures are posted under the "Events" link on the left menu bar.  Please contact Lawrence Lin to learn more about any of the upcoming visits.